
Transthyretin amyloid polyneuropathy, caused by mutations in the transthyretin gene, is a progressive condition for which liver transplantation is an established treatment. Favorable outcomes have been described in patients with the most common transthyretin mutation, Val30Met, but outcomes have been variable in patients with other mutations. We describe the cases of 2 siblings with transthyretin amyloid polyneuropathy secondary to an infrequently reported transthyretin mutation (Ala36Pro) who underwent liver transplantation with poor outcomes.
Adult, Family Health, Male, Amyloid Neuropathies, Familial, Alanine, Genotype, Proline, Amyloid Neuropathies, Liver Transplantation, Familial, Fatal Outcome, Treatment Outcome, Mutation, Humans, Prealbumin, Female
Adult, Family Health, Male, Amyloid Neuropathies, Familial, Alanine, Genotype, Proline, Amyloid Neuropathies, Liver Transplantation, Familial, Fatal Outcome, Treatment Outcome, Mutation, Humans, Prealbumin, Female
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
